Form 8-K - Current report:
SEC Accession No. 0001213900-25-030089
Filing Date
2025-04-09
Accepted
2025-04-09 06:30:57
Documents
13
Period of Report
2025-04-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237667-8k_therap.htm   iXBRL 8-K 23748
  Complete submission text file 0001213900-25-030089.txt   196731

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE txmd-20250408.xsd EX-101.SCH 3032
3 XBRL LABEL FILE txmd-20250408_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE txmd-20250408_pre.xml EX-101.PRE 22370
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0237667-8k_therap_htm.xml XML 3679
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 25823784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)